You have 9 free searches left this month | for more free features.

City

Condition

EGFR Mutant Advanced Non-Small Cell Lung Cancer (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Bridge Biotherapeutics, Inc. (1)

Collaborator

Intervention

bbt-207 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

bbt-207

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

EGFR Mutant Advanced NSCLC Trial (BBT-207)

Not yet recruiting

EGFR Mutant Advanced Non-Small Cell Lung Cancer

BBT-207

(no location specified)

Jun 16, 2023